Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y

BACKGROUND: Previous studies have shown that elosulfase alfa has a favorable efficacy/safety profile in Morquio A patients aged ≥5 y. This study evaluated safety and impact on urine keratan sulfate (uKS) levels and growth velocity in younger patients. METHODS: Fifteen Morquio A patients aged <5 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Simon A., Bialer, Martin, Parini, Rossella, Martin, Ken, Wang, Hui, Yang, Ke, Shaywitz, Adam J., Harmatz, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700045/
https://www.ncbi.nlm.nih.gov/pubmed/26331768
http://dx.doi.org/10.1038/pr.2015.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700045/
https://www.ncbi.nlm.nih.gov/pubmed/26331768
http://dx.doi.org/10.1038/pr.2015.169

Ejemplares similares